131 results
Page 3 of 7
6-K
EX-99.1
4m729dvt66n5z45
3 Sep 14
Live Filing
12:00am
6-K
9ul0d3ht7p
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
6ed yw2e7
24 Jan 14
Live Filing
12:00am
6-K
b5r0ej9ed54us19
17 Jan 14
Current report (foreign)
12:00am
6-K
EX-99.1
ndcj7cp6 8mcgd67y
4 Oct 13
Live Filing
12:00am
6-K
EX-99.1
7pfh6za2e1ll2y7ux
1 Oct 13
Live Filing
12:00am
6-K
EX-99.1
423ygcgkbti
26 Sep 13
Live Filing
12:00am
6-K
EX-99.1
i4c1tpd63foz7o
1 Jul 13
Live Filing
12:00am
6-K
EX-32.1
jrl8w7oupzi
12 Jun 13
Live Filing
12:00am
6-K
EX-99.1
r5l1x0h dbj59
21 Mar 13
Live Filing
12:00am
6-K
twytwwdudibjt he5
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
ldnaet 8rk
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
70a 7hqlgi9d4ibufbmw
6 Mar 13
Live Filing
12:00am
6-K
EX-99.1
i9e1p59x7hfknjt
5 Feb 13
Teva Announces First Patient Enrolled In Largest Clinical Study to Date Evaluating Azilect® for Mild Cognitive Impairment In Parkinson’s Disease
12:00am
6-K
EX-99.1
keteq2m8
10 Oct 12
New Data Presented at the 28TH Ectrims Congress Showcase Teva’s Ongoing Commitment to Multiple Sclerosis Research
12:00am
6-K
EX-99.1
2ou502jmyr8v8 itybp
8 Aug 12
Teva to Initiate Third Phase Iii Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis
12:00am
6-K
tv51kab0vj0po9duum
8 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
9jvneoagbbqrbxx3m
18 Apr 12
Teva Announces New Data on Central Nervous System Products to Be Presented at 2012 American Academy of Neurology Annual Meeting
12:00am